China: Pharmaceutical Trademark Protection In China

Last Updated: 18 July 2016
Article by Yu Li

Most Read Contributor in China, September 2016

The rise in IP litigation involving pharmaceutical trademarks, generic drug names and commodity names suggests that rights holders would do well to develop a trademark strategy for their pharmaceutical products in line with other aspects of IP protection. This is all the more crucial given that registered trademarks benefit from 10 years of protection and unlimited renewals – unlike patents, they can essentially enjoy permanent protection.

Registering pharmaceutical trademarks

Article 12 of the Quality Standard for Pharmaceutical Commodities (Trial Implementation, 1984) states that pharmaceuticals should have registered trademarks. Further, Article 27 of the Provisions of Pharmaceutical Direction and Labels (2006) prohibits pharmaceutical directions and labels from using unregistered trademarks or unapproved commodity names.

Pharmaceutical manufacturers thus need to register a trademark for their products before they enter the market – consumers can then be encouraged to refer to products by the designated trademark right from the start. In the same way, foreign or international enterprises should ensure that they have a Chinese trademark in place before their products are launched on the Chinese market. Case law in this area provides a stark illustration of why such precautions are necessary.

Viagra loses out to official Chinese registration

Pfizer's VIAGRA mark (1130739) was approved for registration in Class 5 for human drugs and medical preparations in China on November 28 1997 and then renewed for two further 10-year terms. Wellman applied to register the mark '伟哥' (1911818) in Class 5 on June 2 1998, with registration granted on June 22 2002. Pfizer applied to register the mark '伟哥', but its application was refused. In *Pfizer Inc v Jiangsu Lianhuan Pharmaceutical Co, Ltd* ((2009) Min Shen Zi No 312) the plaintiff and defendant submitted evidence which clearly demonstrated that, between 1998 and 2003, at least 30 newspapers described '伟哥' as the Chinese translation of 'Viagra'. '伟哥' is also described as the Chinese translation of 'Viagra' in the China Food and Drug Administration's Urgent Notice Concerning the Detainment of Counterfeit '伟哥' Drugs (1999, No 72).

The administration replied to Wellman in Urgent Notice 2000/19 that '伟哥' and its English name 'Viagra' are not the recognised pharmaceutical generic or commodity names of Pfizer's Sildenafil. Pfizer's attorney specifically stated that the commodity name of Viagra is '万艾可', a trademark registration for which is owned by Pfizer in China. Further, Pfizer admitted at first instance that it never used the '伟哥' mark.

Based on this evidence and these facts, the Beijing First Intermediate Court and the Supreme People's Court held that the evidence presented could not prove that '伟哥' was Pfizer's unregistered mark for Viagra. As a result, Pfizer lost trademark rights in '伟哥'.

Non-registrability of pharmaceutical generic names

A pharmaceutical generic name is the statutory name of the pharmaceutical containing its ingredients or formulation, and cannot be registered as a trademark. Article 11 of the Trademark Law (2013) also prohibits the registration of a product's generic name as a trademark. According to Article 59 and based on these regulations, it is clear that a pharmaceutical generic name cannot enjoy trademark rights.

In *Kunming City Lv Hai Yun Dan Trading Co, Ltd v GMP, Kunming Jing Yi Yuan Trading Co, Ltd* (2011, Yun Gao Min San Zhong Zi No 4) the plaintiff and its affiliate company were granted approval to manufacture '舒泌通胶囊' (Shu Mi Tong capsules) on September 8 2000. The plaintiff registered the '舒泌通' mark (4662653) and logo in Class 5. The defendant had manufactured '舒泌通片' (Shu Mi Tong tablets) under the '健发' mark and logo since 2002.

It was found that '舒泌通胶囊' was recognised as a generic name in 2002 and that '舒泌通片' was recognised as generic name in 2009. Considering that '舒泌通' had been recognised as a generic name for Chinese drugs, the plaintiff's claims of trademark infringement and unfair competition were rejected by the court.

Conflicts between commodity names and trademarks

A pharmaceutical commodity name is approved by the pharmaceutical supervisory and administrative department and is usually designed to be straightforward and easy to remember. A pharmaceutical trademark, on the other hand, is a mark which can serve to identify the source of the goods. It can be made up of text, graphics, letters, numbers, three-dimensional marks, colour combinations and sounds, as well as combinations of these elements, including the pharmaceutical commodity.

Considering that these names are regulated separately by the Drug Administration Law and the Trademark Law respectively, it is little wonder that conflicts between trademarks and commodity names often bring rights holders before the courts.

In *Wang Liang v Wuhan Administration for Industry and Commerce*, Shanxi Ya Bao Pharmaceutical Group Co, Ltd applied to register '丁桂' (3248395) – a combination of the Chinese names for clove and cinnamon – in Class 5 for tablets, patches and ointments in 2002. The mark was approved for registration on November 21 2013.

Wuhan City San Chu Technology Development Co, Ltd used the marks '丁桂宝' and '丁桂姜' on its paediatric diarrhoea medicine, with the packaging carrying the letters 'TM' on the top right. The official reply sent by the Trademark Office to the relevant administration for industry and commerce (AIC) on January 7 2006 mentioned that '丁桂儿剂贴' is the commodity name of a traditional Chinese drug whose ingredients include cloves ('丁香') and cinnamon ('肉桂'). According to Chinese proprietary naming rules, compound traditional Chinese drugs can be named by condensing the names of the main ingredients. Thus while the trademark owner could not prevent others from using '丁桂' to describe drugs containing cloves and cinnamon, the use should be limited to explaining the drug's ingredients. In this case, '丁桂宝' and '丁桂姜' were marked with 'TM' – the use thus constituted trademark infringement. The case was selected as one of the Supreme People's Procuratorate's top 10 typical IP cases of 2013.

In *Jilin Province Northern Pharmaceutical Co, Ltd v Jilin Province Hu Mua Animal Health Products Co, Ltd* (2015, Chang Min San Chu Zi No 82), the plaintiff applied to register the trademark '感康' (1775614) on December 17 1998 for human drugs in Class 5, with approval granted on May 28 2002. The mark was designated as being well known by the AIC in 2007. '华牧感康' was the commodity name of the defendant's lincomycin hydrochloride injection, which was approved by Jilin Province's animal husbandry authority as an animal drug on July 1997. '华牧感康' appeared prominently on the packaging of the defendant's poultry medicine. The court finally judged that '华牧感康' and '感康' constituted similar marks, human drugs and animal drugs were similar goods and the behaviour of the defendants constituted trademark infringement.

In this case, the defendant's commodity name was registered before the application date of the plaintiff's trademark. However, the use of the commodity name was still recognised as trademark infringement by the court. According to Article 59.3 of the Trademark Law, where an identical or similar trademark with certain influence has been used for the same or similar goods by others before the application is filed, the exclusive rights holder may not prohibit the user of the aforesaid trademark from continuous use of such within the original scope. However, it may request that the user affix additional logos in order to distinguish between the products.

The following conditions apply in order to cite this provision to defend against a plaintiff's claims:

  • The use of the commodity name must be earlier than the application date of the trademark; and
  • The commodity name was famous.

The evidence submitted by the defendant was insufficient to prove that the commodity name had been used before the application date of the trademark at issue. It also failed to prove that the commodity name at issue enjoyed a significant reputation in China.


To succeed in the Chinese pharmaceutical market, an enterprise should establish its trademark registration strategy at the same time as it develops its new drugs so that the drugs are protected by registration before they launch. Applications should avoid using generic names to ensure that exclusive rights can be obtained. Finally, while it is possible to use a commodity name which is similar to a registered trademark, such use should be carefully limited. A commodity name should never be used as a trademark, to avoid a finding of infringement.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.